Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IOL Chemicals And PharmaceuticalsNSE:IOLCP +2.86%59 Shiller PE Ratio is 22.29 as of Aug. 08, 2026, which is 39% above its 10-year median of 16.09. GuruFocus rates NSE:IOLCP with a GF Score™ of 59/100 and a GF Value™ of ₹95.17 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 533 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks better than 61.54% on this metric.
The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:
NSE:IOLCP'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.41 Med: 16.09 Max: 48.67
Current: 22.28
During the past years, IOL Chemicals And Pharmaceuticals's highest Shiller PE Ratio was 48.67. The lowest was 9.41. And the median was 16.09.
NSE:IOLCP's Shiller PE Ratio is ranked better than 61.54% of 533
companies
in the Drug Manufacturers industry
Industry Median: 25.67
vs NSE:IOLCP: 22.28
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
IOL Chemicals And Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹1.810. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹7.53 for the trailing ten years ended in Mar. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
IOL Chemicals And Pharmaceuticals Shiller PE Ratio Related Terms
IOL Chemicals And Pharmaceuticals Shiller PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOL Chemicals And Pharmaceuticals Shiller PE Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IOL Chemicals And Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Shiller PE Ratio falls into.
IOL Chemicals And Pharmaceuticals Shiller PE Ratio Calculation
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Shiller PE Ratio of 22.29 as of Aug. 08, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. This is 39% above median its historical median of 16.09. Over the past decade, IOL Chemicals And Pharmaceuticals' Shiller PE Ratio has ranged from 9.41 to 48.67. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #205 out of 533 companies in the Drug Manufacturers industry, placing it in the top 38.5%.
Is IOL Chemicals And Pharmaceuticals' Shiller PE Ratio too high?
IOL Chemicals And Pharmaceuticals' current Shiller PE Ratio of 22.29 is 39% above median its 10-year median of 16.09. Over the past 10 years, this metric has ranged from a low of 9.41 to a high of 48.67. The Drug Manufacturers industry median Shiller PE Ratio is 25.67. IOL Chemicals And Pharmaceuticals' value of 22.29 is 13.2% below this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #205 out of 533 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Shiller PE Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #205 out of 533 companies for Shiller PE Ratio. This puts IOL Chemicals And Pharmaceuticals in the upper half of its industry. The industry median Shiller PE Ratio is 25.67. IOL Chemicals And Pharmaceuticals' value of 22.29 is 13.2% below this benchmark. Historically, IOL Chemicals And Pharmaceuticals' own Shiller PE Ratio has ranged from 9.41 to 48.67 over the past decade. While the company's 10-year median is 16.09 vs. the industry median of 25.67, IOL Chemicals And Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Drug Manufacturers company?
The median Shiller PE Ratio among Drug Manufacturers companies is 25.67, based on 533 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current Shiller PE Ratio of 22.29 is 13.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Shiller PE Ratio is 25.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current Shiller PE Ratio is 22.29, which is 39% above median its own 10-year median of 16.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹95.17, compared to a current price of ₹167.85 — trading 76.4% above its estimated fair value. The current Shiller PE Ratio is 22.29, which is 39% above median its 10-year median of 16.09 and 13.2% below the Drug Manufacturers industry median of 25.67. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Shiller PE Ratio is 22.29 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹167.85 is trading 76.4% above its estimated GF Value™ of ₹95.17.
GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:IOLCP:
Shiller PE Ratio: 22.29 (39% above median its 10-year median of 16.09)
GF Value™: ₹95.17 vs. price of ₹167.85 (76.4% above fair value)
Industry Position: 13.2% below the Drug Manufacturers median (#205 of 533)
No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
59GF Score
Get the complete analysis for NSE:IOLCP
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IOLCP has been successfully added to your 
